CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Author
A Corso
A Glasmacher
+36 more
A Glasmacher
A Glasmacher
A Glasmacher
A Palumbo
A Suvannasankha
Axel Glasmacher
B Barlogie
B Barlogie
BGM Durie
Britta Auel
C Kyriakou
Christof Scheid
F Ong
FE Davies
G Cook
G Sidra
Hans-Jürgen Salwender
Hartmut Goldschmidt
Holger Nückel
I Breitkreutz
Igor Blau
Ingo G. H. Schmidt-Wolf
J Bladé
Katja Weisel
M Attal
Marcus Gorschlüter
Mathias Hänel
R Alexanian
Ralph Naumann
S Kumar
S Singhal
Thomas Geer
Thomas M. Moehler
TM Moehler
Uwe Platzbecker
Wolfgang Knauf
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
No full text
